Kelt: thanks for digging into this...and it wou
Post# of 72440
(Total Views: 382)
Posted On: 03/21/2020 8:47:18 AM
Kelt:
thanks for digging into this...and it would be useful to get a response from USA Today. In the article from snook, it states the following:
Innovation Pharmaceuticals is evaluating Brilacidin, what is called a defensin mimetic drug candidate, as a potential treatment for coronavirus. The drug has demonstrated antibacterial, anti-inflammatory and immunomodulatory activity in several clinical trials.
Inovio Pharmaceuticals is collaborating with Beijing Advaccine Biotechnology on Inovio’s vaccine, INO-4800, against the coronavirus. It has launched preclinical testing for clinical product manufacturing. It is supported by a $9 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI). Inovio’s INO-4700, an investigational DNA immunotherapy, is also being developed in partnership with GeneOne Life Science. It was originally developed for MERS.
thanks for digging into this...and it would be useful to get a response from USA Today. In the article from snook, it states the following:
Innovation Pharmaceuticals is evaluating Brilacidin, what is called a defensin mimetic drug candidate, as a potential treatment for coronavirus. The drug has demonstrated antibacterial, anti-inflammatory and immunomodulatory activity in several clinical trials.
Inovio Pharmaceuticals is collaborating with Beijing Advaccine Biotechnology on Inovio’s vaccine, INO-4800, against the coronavirus. It has launched preclinical testing for clinical product manufacturing. It is supported by a $9 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI). Inovio’s INO-4700, an investigational DNA immunotherapy, is also being developed in partnership with GeneOne Life Science. It was originally developed for MERS.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼